Please try another search
For the fiscal year ended 31 December 2019, EagleHealth Holdings Ltd revenues decreased 7% to A$103.2M. Netincome applicable to common stockholders decreased 55% toA$8.5M. Revenues reflect a decrease in demand for theCompany's products and services due to unfavorable marketconditions. Net income also reflects Research anddevelopment expenses increase of 36% to A$3.9M (expense).
Period Ending: | Dec 31, 2019 | Jun 30, 2019 | Dec 31, 2018 | Jun 30, 2018 |
---|---|---|---|---|
Total Revenue | 58.67 | 44.53 | 69.28 | 41.73 |
Gross Profit | 28.36 | 21.1 | 35.66 | 21.12 |
Operating Income | 8.44 | 4.45 | 18.74 | 6.89 |
Net Income | 6.01 | 2.5 | 13.89 | 4.85 |
Period Ending: | Dec 31, 2019 | Jun 30, 2019 | Dec 31, 2018 | Jun 30, 2018 |
---|---|---|---|---|
Total Assets | 104.89 | 94.59 | 96.39 | 74.69 |
Total Liabilities | 19.88 | 16.21 | 20.72 | 12.92 |
Total Equity | 85.01 | 78.37 | 75.67 | 61.77 |
Period Ending: | Dec 31, 2019 | Jun 30, 2019 | Dec 31, 2018 | Jun 30, 2018 |
---|---|---|---|---|
Period Length: | 12 Months | 6 Months | 12 Months | 6 Months |
Cash From Operating Activities | -25 | -19.49 | -1.46 | 6.48 |
Cash From Investing Activities | -0.03 | -0 | -5.72 | -5.25 |
Cash From Financing Activities | 1.42 | 0.31 | 3.13 | -0.03 |
Net Change in Cash | -24.12 | -18.99 | -2.22 | 2.42 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review